Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02823574 · COMPLETED
Trial details
- NCT number
- NCT02823574
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-08
- Primary completion
- 2019-01-23
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.